Functional effects of virgin flaxseed oil on nutrigenomics regulation in a rat model of obesity

IF 0.3 Q4 NUTRITION & DIETETICS
CAHIERS DE NUTRITION ET DE DIETETIQUE Pub Date : 2026-08-01 Epub Date: 2026-09-24 DOI:10.1016/j.cnd.2026.08.029
Emilse Negro, Carolina Gerstner, Claudio Bernal
{"title":"Functional effects of virgin flaxseed oil on nutrigenomics regulation in a rat model of obesity","authors":"Emilse Negro,&nbsp;Carolina Gerstner,&nbsp;Claudio Bernal","doi":"10.1016/j.cnd.2026.08.029","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are associated with altered lipid metabolism, inflammation, and increased cardiovascular risk.</div></div><div>Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are associated with altered lipid metabolism, inflammation, and increased cardiovascular risk.</div><div><h3>Objective</h3><div>This study evaluated the nutrigenomic effects of diets containing virgin flaxseed oil (VFO), compared with animal fat and soybean oil, on metabolic parameters, hepatic fatty acid (FA) profile, and expression of genes involved in lipid metabolism in diet-induced obese rats.</div></div><div>This study evaluated the nutrigenomic effects of diets containing virgin flaxseed oil (VFO), compared with animal fat and soybean oil, on metabolic parameters, hepatic fatty acid (FA) profile, and expression of genes involved in lipid metabolism in diet-induced obese rats.</div><div><h3>Methods</h3><div>Male Wistar rats received for 90 days either a control diet containing 4% soybean oil (S4, <em>n</em> <!-->=<!--> <!-->6) or an obesogenic diet containing 20% fructose and 20% animal fat (OB, <em>n</em> <!-->=<!--> <!-->24). Ethics Committees: # CE2020-64. At the end of this period, six animals from S4 and six from OB were euthanized. Remaining OB animals continued for 60 additional days with diets containing 4% soybean oil, animal fat, or VFO, forming OBS4 (<em>n</em> <!-->=<!--> <!-->6), OBGA4 (<em>n</em> <!-->=<!--> <!-->6), and OBVFO4 (<em>n</em> <!-->=<!--> <!-->6). Anthropometric parameters, serum and hepatic triglycerides (TG), hepatic FA profile, and gene expression of enzymes and transcription factors were assessed by RT-qPCR.</div></div><div>Male Wistar rats received for 90 days either a control diet containing 4% soybean oil (S4, <em>n</em> <!-->=<!--> <!-->6) or an obesogenic diet containing 20% fructose and 20% animal fat (OB, <em>n</em> <!-->=<!--> <!-->24). Ethics Committees: # CE2020-64. At the end of this period, six animals from S4 and six from OB were euthanized. Remaining OB animals continued for 60 additional days with diets containing 4% soybean oil, animal fat, or VFO, forming OBS4 (<em>n</em> <!-->=<!--> <!-->6), OBGA4 (<em>n</em> <!-->=<!--> <!-->6), and OBVFO4 (<em>n</em> <!-->=<!--> <!-->6). Anthropometric parameters, serum and hepatic triglycerides (TG), hepatic FA profile, and gene expression of enzymes and transcription factors were assessed by RT-qPCR.</div><div><h3>Results</h3><div>After 90 days, the OB diet increased energy intake, body weight, adipose tissue mass, and serum and hepatic TG levels (<em>P</em> <!-->&lt;<!--> <!-->0.05 vs. S4). At the hepatic level, reduced flux through stearoyl-CoA desaturase-1 (SCD1) was evidenced by decreased palmitoleic/palmitic and oleic/stearic acid ratios, along with an increased arachidonic acid/eicosapentaenoic acid ratio. In addition, decreased expression of genes involved in lipogenesis (FAS, ACC, and SCD1) and FA oxidation (ACOX1 and CPT1a) were observed, together with increased expression of the FA transporter FATP2. Following the intervention, VFO significantly reduced serum and hepatic TG, improved the hepatic FA profile (higher α-linolenic acid/linoleic acid ratio and lower arachidonic acid/eicosapentaenoic acid ratio), and modulated hepatic gene expression by decreasing SREBP1c, FAS, SCD1, and SREBP1a, while increasing PPARα expression.</div></div><div>After 90 days, the OB diet increased energy intake, body weight, adipose tissue mass, and serum and hepatic TG levels (<em>P</em> <!-->&lt;<!--> <!-->0.05 vs. S4). At the hepatic level, reduced flux through stearoyl-CoA desaturase-1 (SCD1) was evidenced by decreased palmitoleic/palmitic and oleic/stearic acid ratios, along with an increased arachidonic acid/eicosapentaenoic acid ratio. In addition, decreased expression of genes involved in lipogenesis (FAS, ACC, and SCD1) and FA oxidation (ACOX1 and CPT1a) were observed, together with increased expression of the FA transporter FATP2. Following the intervention, VFO significantly reduced serum and hepatic TG, improved the hepatic FA profile (higher α-linolenic acid/linoleic acid ratio and lower arachidonic acid/eicosapentaenoic acid ratio), and modulated hepatic gene expression by decreasing SREBP1c, FAS, SCD1, and SREBP1a, while increasing PPARα expression.</div><div><h3>Conclusion</h3><div>Overall, these findings suggest a hepatoprotective and anti-inflammatory effect of VFO, possibly mediated by n-3 FA and their derivatives, whichpleiotropically regulate genes involved in lipid synthesis and oxidation pathways.</div></div><div>Overall, these findings suggest a hepatoprotective and anti-inflammatory effect of VFO, possibly mediated by n-3 FA and their derivatives, whichpleiotropically regulate genes involved in lipid synthesis and oxidation pathways.</div>","PeriodicalId":43722,"journal":{"name":"CAHIERS DE NUTRITION ET DE DIETETIQUE","volume":"61 ","pages":"Pages e16-e17"},"PeriodicalIF":0.3000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CAHIERS DE NUTRITION ET DE DIETETIQUE","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0007996026001057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are associated with altered lipid metabolism, inflammation, and increased cardiovascular risk.
Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are associated with altered lipid metabolism, inflammation, and increased cardiovascular risk.

Objective

This study evaluated the nutrigenomic effects of diets containing virgin flaxseed oil (VFO), compared with animal fat and soybean oil, on metabolic parameters, hepatic fatty acid (FA) profile, and expression of genes involved in lipid metabolism in diet-induced obese rats.
This study evaluated the nutrigenomic effects of diets containing virgin flaxseed oil (VFO), compared with animal fat and soybean oil, on metabolic parameters, hepatic fatty acid (FA) profile, and expression of genes involved in lipid metabolism in diet-induced obese rats.

Methods

Male Wistar rats received for 90 days either a control diet containing 4% soybean oil (S4, n = 6) or an obesogenic diet containing 20% fructose and 20% animal fat (OB, n = 24). Ethics Committees: # CE2020-64. At the end of this period, six animals from S4 and six from OB were euthanized. Remaining OB animals continued for 60 additional days with diets containing 4% soybean oil, animal fat, or VFO, forming OBS4 (n = 6), OBGA4 (n = 6), and OBVFO4 (n = 6). Anthropometric parameters, serum and hepatic triglycerides (TG), hepatic FA profile, and gene expression of enzymes and transcription factors were assessed by RT-qPCR.
Male Wistar rats received for 90 days either a control diet containing 4% soybean oil (S4, n = 6) or an obesogenic diet containing 20% fructose and 20% animal fat (OB, n = 24). Ethics Committees: # CE2020-64. At the end of this period, six animals from S4 and six from OB were euthanized. Remaining OB animals continued for 60 additional days with diets containing 4% soybean oil, animal fat, or VFO, forming OBS4 (n = 6), OBGA4 (n = 6), and OBVFO4 (n = 6). Anthropometric parameters, serum and hepatic triglycerides (TG), hepatic FA profile, and gene expression of enzymes and transcription factors were assessed by RT-qPCR.

Results

After 90 days, the OB diet increased energy intake, body weight, adipose tissue mass, and serum and hepatic TG levels (P < 0.05 vs. S4). At the hepatic level, reduced flux through stearoyl-CoA desaturase-1 (SCD1) was evidenced by decreased palmitoleic/palmitic and oleic/stearic acid ratios, along with an increased arachidonic acid/eicosapentaenoic acid ratio. In addition, decreased expression of genes involved in lipogenesis (FAS, ACC, and SCD1) and FA oxidation (ACOX1 and CPT1a) were observed, together with increased expression of the FA transporter FATP2. Following the intervention, VFO significantly reduced serum and hepatic TG, improved the hepatic FA profile (higher α-linolenic acid/linoleic acid ratio and lower arachidonic acid/eicosapentaenoic acid ratio), and modulated hepatic gene expression by decreasing SREBP1c, FAS, SCD1, and SREBP1a, while increasing PPARα expression.
After 90 days, the OB diet increased energy intake, body weight, adipose tissue mass, and serum and hepatic TG levels (P < 0.05 vs. S4). At the hepatic level, reduced flux through stearoyl-CoA desaturase-1 (SCD1) was evidenced by decreased palmitoleic/palmitic and oleic/stearic acid ratios, along with an increased arachidonic acid/eicosapentaenoic acid ratio. In addition, decreased expression of genes involved in lipogenesis (FAS, ACC, and SCD1) and FA oxidation (ACOX1 and CPT1a) were observed, together with increased expression of the FA transporter FATP2. Following the intervention, VFO significantly reduced serum and hepatic TG, improved the hepatic FA profile (higher α-linolenic acid/linoleic acid ratio and lower arachidonic acid/eicosapentaenoic acid ratio), and modulated hepatic gene expression by decreasing SREBP1c, FAS, SCD1, and SREBP1a, while increasing PPARα expression.

Conclusion

Overall, these findings suggest a hepatoprotective and anti-inflammatory effect of VFO, possibly mediated by n-3 FA and their derivatives, whichpleiotropically regulate genes involved in lipid synthesis and oxidation pathways.
Overall, these findings suggest a hepatoprotective and anti-inflammatory effect of VFO, possibly mediated by n-3 FA and their derivatives, whichpleiotropically regulate genes involved in lipid synthesis and oxidation pathways.
初榨亚麻籽油对肥胖大鼠营养基因组学调节的功能影响
背景:肥胖和代谢功能障碍相关的脂肪变性肝病(MASLD)与脂质代谢改变、炎症和心血管风险增加有关。肥胖和代谢功能障碍相关的脂肪变性肝病(MASLD)与脂质代谢改变、炎症和心血管风险增加有关。目的研究含亚麻籽油(VFO)的饮食对肥胖大鼠代谢参数、肝脂肪酸(FA)谱和脂质代谢相关基因表达的营养基因组学影响,并与动物脂肪和大豆油进行比较。本研究评估了与动物脂肪和大豆油相比,含有初生亚麻籽油(VFO)的饮食对饮食诱导肥胖大鼠代谢参数、肝脂肪酸(FA)谱和脂质代谢相关基因表达的营养基因组学影响。方法雄性Wistar大鼠分别饲喂含4%大豆油的对照组(S4, n = 6)和含20%果糖和20%动物脂肪的致肥性饲粮(OB, n = 24),为期90 d。伦理委员会:# CE2020-64在这段时间结束时,来自S4的6只动物和来自OB的6只动物被安乐死。其余OB动物继续饲喂含有4%大豆油、动物脂肪或VFO的饲粮60天,形成ob4 (n = 6)、OBGA4 (n = 6)和OBVFO4 (n = 6)。采用RT-qPCR方法评估人体测量参数、血清和肝脏甘油三酯(TG)、肝脏FA谱以及酶和转录因子的基因表达。雄性Wistar大鼠接受90天的对照组饮食(S4, n = 6)或致肥性饮食(OB, n = 24),对照组饮食中含有4%大豆油(S4, n = 6)或致肥性饮食中含有20%果糖和20%动物脂肪(OB, n = 24)。伦理委员会:# CE2020-64在这段时间结束时,来自S4的6只动物和来自OB的6只动物被安乐死。其余OB动物继续饲喂含有4%大豆油、动物脂肪或VFO的饲粮60天,形成ob4 (n = 6)、OBGA4 (n = 6)和OBVFO4 (n = 6)。采用RT-qPCR方法评估人体测量参数、血清和肝脏甘油三酯(TG)、肝脏FA谱以及酶和转录因子的基因表达。结果90 d后,OB饮食增加了能量摄入、体重、脂肪组织质量以及血清和肝脏TG水平(P < 0.05 vs. S4)。在肝脏水平,通过硬脂酰辅酶a去饱和酶-1 (SCD1)的通量降低,表现为棕榈油酸/棕榈酸和油酸/硬脂酸比值降低,花生四烯酸/二十碳五烯酸比值升高。此外,脂肪生成相关基因(FAS、ACC和SCD1)和FA氧化相关基因(ACOX1和CPT1a)的表达减少,同时FA转运体FATP2的表达增加。干预后,VFO显著降低了血清和肝脏TG,改善了肝脏FA谱(α-亚麻酸/亚油酸比值升高,花生四烯酸/二十碳五烯酸比值降低),并通过降低SREBP1c、FAS、SCD1和SREBP1a,增加PPARα表达来调节肝脏基因表达。90天后,OB日粮增加了能量摄入、体重、脂肪组织质量以及血清和肝脏TG水平(P < 0.05 vs. S4)。在肝脏水平,通过硬脂酰辅酶a去饱和酶-1 (SCD1)的通量降低,表现为棕榈油酸/棕榈酸和油酸/硬脂酸比值降低,花生四烯酸/二十碳五烯酸比值升高。此外,脂肪生成相关基因(FAS、ACC和SCD1)和FA氧化相关基因(ACOX1和CPT1a)的表达减少,同时FA转运体FATP2的表达增加。干预后,VFO显著降低了血清和肝脏TG,改善了肝脏FA谱(α-亚麻酸/亚油酸比值升高,花生四烯酸/二十碳五烯酸比值降低),并通过降低SREBP1c、FAS、SCD1和SREBP1a,增加PPARα表达来调节肝脏基因表达。综上所述,这些发现提示VFO具有保护肝脏和抗炎作用,可能是由n- 3fa及其衍生物介导的,其多效性调节参与脂质合成和氧化途径的基因。总的来说,这些发现表明VFO具有肝脏保护和抗炎作用,可能是由n- 3fa及其衍生物介导的,其多效性调节参与脂质合成和氧化途径的基因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CAHIERS DE NUTRITION ET DE DIETETIQUE
CAHIERS DE NUTRITION ET DE DIETETIQUE NUTRITION & DIETETICS-
CiteScore
0.60
自引率
33.30%
发文量
55
审稿时长
65 days
期刊介绍: Les Cahiers de nutrition et de diététique sont le lieu de communication reconnu pour les médecins spécialistes de la nutrition, les diététiciens, les professionnels et les chercheurs de agro-alimentaire, les enseignants et les étudiants. Les Cahiers de nutrition et de diététique abordent les sujets se rapportant à la biologie générale, à la médecine et à la nutrition, aux aliments, aux comportements alimentaires, à la diététique pratique, ainsi que des thèmes variés : activité physique, apports nutritionnels conseillés, dénutrition, alcool, obésité de enfant, aliments à effet santé, plaisir alimentaire, restauration collective, goûters et collations, allergies alimentaires...
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书